ClinicaliQ Trial Snapshot
- Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing — Active Not Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT04798768.
- New modular pacemaker and implantable defibrillator system tested for safety and effectiveness in treating abnormal heart rhythms.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The MODULAR ATP Clinical Study is designed to demonstrate safety, performance, and effectiveness of the Modular Cardiac Rhythm Management (mCRM) Therapy System. Conditions: Tachycardia, Ventricular, Arrhythmia, Ventricular Interventions: mCRM Therapy System Lead Sponsor: Boston Scientific Corporation Planned Enrollment: 297 participants